Plain-English translation of NCT05584267 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new approach to treating non-small cell lung cancer that has spread to the brain. Researchers are combining chemotherapy and immunotherapy with different types of radiation therapy to see which combination works best. The goal is to develop a system that helps doctors choose the most effective treatment plan for each patient based on their individual tumor characteristics.
Brain metastases from lung cancer are difficult to treat and often have poor outcomes. This trial exists to find out whether combining multiple types of treatment—chemotherapy, immunotherapy, and precision radiation—can improve survival and quality of life for patients with this condition.
You likely qualify if…
You likely don't qualify if…
You would receive chemotherapy every three weeks for up to four cycles, combined with immunotherapy. Depending on which group you are assigned to, you would also receive either whole-brain radiation (10 sessions) or focused high-dose radiation (3 sessions). Throughout the trial, you would have imaging scans and blood tests to monitor how well the treatment is working and to help doctors understand your tumor's characteristics.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China